Xcelerate, Inc. to Develop Consumer Healthcare Products Based on Its Current Patent Portfolio. MAULDIN, SC / ACCESSWIRE / August 30, 2022 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it had begun an initiative to identify marketing/manufacturing
MAULDIN, SC / ACCESSWIRE / August 23, 2022 / Xcelerate, Inc. (OTCQB:XCRT) today announced that it has received patent protection in nine additional countries Korean Claim – In April 2022 our Korean Application, #10-2019-7006227, was allowed
Mauldin, SC., August 2, 2022 –Xcelerate, Inc. (OTC Markets: “XCRT”) today announced that its C.E.O., Michael O’Shea will be interviewed by Tiger Free Stock today announced that its C.E.O., Michael O’Shea will be interviewed by Tiger
MAULDIN, SC / ACCESSWIRE / August 1, 2022 / Xcelerate, Inc. (OTCQB:XCRT), today announces that the OTC Market Group has approved the Company’s application for uplisting to the OTCQB® Venture Market (the “OTCQB”). The Company will
MAULDIN, SC / ACCESSWIRE / June 22, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it has initiated its plan to upgrade the trading of its common stock from the OTC Pink Market to the
MAULDIN, SC / ACCESSWIRE / June 7, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that Cathy Scangarella has accepted an invitation to join its Advisory Board effective immediately. Cathy Scangarella is the Chief Business Development
Wilken, O’Shea Talk Acquisition of HS Pharmaceuticals and What It Means for The Future Of XCRT CEO Mike O’Shea of Xcelerate, Inc., a development stage startup focused on the development of cutting-edge medtech applications, met
MAULDIN, SC / ACCESSWIRE / May 11, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) recently announced that it had signed a purchase agreement to acquire a portfolio of patents, patents pending and technology licenses from HS
MAULDIN, SC / ACCESSWIRE / May 4, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it signed a purchase agreement to acquire a portfolio of patents, patents pending and technology licenses from HS Pharmaceuticals
MAULDIN, SC / ACCESSWIRE / April 14, 2022 / Xcelerate, Inc. (OTC Markets:XCRT) today announced it has retained SmallCapVoice.com Inc., an Austin, Texas-based investor relations and communications firm focused on socially responsible investments and companies.
AUSTIN, Texas, Apr 04, 2022 (GLOBE NEWSWIRE via COMTEX) — AUSTIN, Texas, April 04, 2022 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc.
MAULDIN, SC / ACCESSWIRE / March 25, 2022 / Xcelerate, Inc. (OTC Markets:XCRT) recently announced that it signed a Membership Interest Purchase Agreement to acquire a 51% interest in AfiyaSasa Africa, LLC, (“ASA”) a start-up
MAULDIN, SC / ACCESSWIRE / March 17, 2022 / Xcelerate, Inc. (OTCMarkets:”XCRT) today announced that Thomas E. Mannle, Jr. has accepted an invitation to join its Advisory Board effective immediately. Thomas holds a B.S. from
MAULDIN, SC / ACCESSWIRE / March 14, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) As recently announced, the Company has acquired majority control in AfiyaSasa Africa, LLC. (“ASA”), a medical technology and virtual health company that
AUSTIN, Texas, March 10, 2022 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Pink: XCRT), to discuss how the Company is utilizing
Mauldin, SC, March 09, 2022 (GLOBE NEWSWIRE) — Xcelerate, Inc. (XCRT) Michael O’Shea, CEO, today released a shareholder update. “As recently announced, Xcelerate has acquired a 51% membership interest in AfiyaSasa Africa, LLC (“ASA”) (Swahili “Health
Mauldin, SC, Jan. 25, 2022 (GLOBE NEWSWIRE) — Xcelerate, Inc. (OTC Pink: XCRT) today announced that it has filed a Supplemental Report with OTC Markets to remove the “shell’ status symbol from the OTC Markets
Mauldin, SC, Jan. 12, 2022 (GLOBE NEWSWIRE) — Xcelerate, Inc. (OTC PINK: XCRT) Mike O’Shea, CEO, today released a shareholder update. 2021 has proven to be a formative year for Xcelerate during which we achieved reporting status
MAULDIN, S.C., Jan. 3, 2022 /PRNewswire/ — Xcelerate, Inc. (OTC pink sheets: “XCRT”) today announced it has signed a Membership Interest Purchase Agreement to acquire a 51% interest in AfiyaSasa Africa, LLC, (“ASA”) a start-up
MAULDIN, S.C., Aug. 26, 2021 /PRNewswire/ — Xcelerate, Inc. (OTC pink sheets: “XCRT”) today announced that it has signed a Definitive Memorandum of Understanding with HS Pharmaceuticals, LLC of Greenville, SC defining the terms under
MAULDIN, S.C., July 29, 2021 /PRNewswire/ — Xcelerate, Inc. (OTC Pink Sheets: “XCRT”) today announced the completion of the audit of its Consolidated Annual Financial Statements for the fiscal years ending December 31, 2019, and
MAULDIN, S.C., June 22, 2021 /PRNewswire/ — Xcelerate, Inc. (OTC Pink Sheets: “XCRT”) today announced it has retained BF Borgers CPA PC as the company’s independent accountant to audit its financial statements for years ending
Brings innovative engineering solutions, medtech producers, and clinical care settings into a unified system.
